M. Freund, E. Speyer: Über die Umwandlung von Thebain in Oxycodeinon und dessen Derivate. In: Journal für Praktische Chemie, Band94, Nr. 1, 1917, S.135–178. doi:10.1002/prac.19160940112
K. Simpson, P. Leyendecker, M. Hopp, S. Müller-Lissner, O. Löwenstein, J. De Andrés, J. Troy Ferrarons, B. Bosse, B. Krain, T. Nichols, W. Kremers, K. Reimer: Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain. In: Current medical research and opinion, Dezember 2008, Band24, Nr. 12, S.3503–3512, doi:10.1185/03007990802584454. PMID 19032132.
B. Scheidel, M. A. Maritz, Y. J. Gschwind, K. Steigerwald, V. Guth, P. Kovacs, H. Rey: Bioavailability of oxycodone after administration of a new prolonged-release once-daily tablet formulation in healthy subjects, in comparison to an established twice-daily tablet. In: Int J Clin Pharmacol Ther., November 2017, Band 55, Nr. 11, S. 881–890. PMID 28933336
B. A. Goldberger, C. W. Chronister, M. L. Merves: Quantitation of oxycodone in blood and urine using gas chromatography-mass spectrometry (GC-MS). In: Methods Mol Biol., 2010, Band 603, S. 453–460. PMID 20077097
J. Jones, K. Tomlinson, C. Moore: The simultaneous determination of codeine, morphine, hydrocodone, hydromorphone, 6-acetylmorphine, and oxycodone in hair and oral fluid. In: J Anal Toxicol., April 2002, Band 26, Nr. 3, S. 171–175. PMID 11991534
R. Kronstrand, M. Forsman, M. Roman: Quantitative analysis of drugs in hair by UHPLC high resolution mass spectrometry. In: Forensic Sci Int., Februar 2018, Band 283, S. 9–15. PMID 29241093
K. L. Johnson-Davis, A. J. Sadler, J. R. Genzen: A Retrospective Analysis of Urine Drugs of Abuse Immunoassay True Positive Rates at a National Reference Laboratory. In: J Anal Toxicol., März 2016, Band 40, Nr. 2, S. 97–107. PMID 26668238
R. B. Dixon, B. Davis, A. Dasgupta: Comparison of Response of DRI Oxycodone Semiquantitative Immunoassay With True Oxycodone Values Determined by Liquid Chromatography Combined With Tandem Mass Spectrometry: Sensitivity of the DRI Assay at 100 ng/ml Cut-Off and Validity of Semiquantitative Value. In: J Clin Lab Anal., Mai 2016, Band 30, Nr. 3, S. 190–195. PMID 25715994
Rachel Wightman, Jeanmarie Perrone, Ian Portelli, Lewis Nelson:Likeability and Abuse Liability of Commonly Prescribed Opioids. In: Journal of Medical Toxicology. 1.Dezember 2012, PMC3550270(freier Volltext).
K. Simpson, P. Leyendecker, M. Hopp, S. Müller-Lissner, O. Löwenstein, J. De Andrés, J. Troy Ferrarons, B. Bosse, B. Krain, T. Nichols, W. Kremers, K. Reimer: Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain. In: Current medical research and opinion, Dezember 2008, Band24, Nr. 12, S.3503–3512, doi:10.1185/03007990802584454. PMID 19032132.